JP2021518149A5 - - Google Patents
Info
- Publication number
- JP2021518149A5 JP2021518149A5 JP2020550874A JP2020550874A JP2021518149A5 JP 2021518149 A5 JP2021518149 A5 JP 2021518149A5 JP 2020550874 A JP2020550874 A JP 2020550874A JP 2020550874 A JP2020550874 A JP 2020550874A JP 2021518149 A5 JP2021518149 A5 JP 2021518149A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- sequence represented
- density lipoprotein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024193020A JP2025023986A (ja) | 2018-03-26 | 2024-11-01 | 免疫細胞増殖を促進する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810251875.7 | 2018-03-26 | ||
| CN201810251875 | 2018-03-26 | ||
| PCT/CN2019/079576 WO2019184886A1 (zh) | 2018-03-26 | 2019-03-25 | 促进免疫细胞增殖的方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024193020A Division JP2025023986A (ja) | 2018-03-26 | 2024-11-01 | 免疫細胞増殖を促進する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021518149A JP2021518149A (ja) | 2021-08-02 |
| JP2021518149A5 true JP2021518149A5 (https=) | 2024-11-21 |
Family
ID=68059463
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550874A Pending JP2021518149A (ja) | 2018-03-26 | 2019-03-25 | 免疫細胞増殖を促進する方法 |
| JP2024193020A Pending JP2025023986A (ja) | 2018-03-26 | 2024-11-01 | 免疫細胞増殖を促進する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024193020A Pending JP2025023986A (ja) | 2018-03-26 | 2024-11-01 | 免疫細胞増殖を促進する方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12005080B2 (https=) |
| EP (1) | EP3778876A4 (https=) |
| JP (2) | JP2021518149A (https=) |
| CN (1) | CN111918964B (https=) |
| WO (1) | WO2019184886A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022206975A1 (zh) * | 2021-04-02 | 2022-10-06 | 原启生物科技(上海)有限责任公司 | Cldn18.2抗原结合蛋白及其用途 |
| CN117136199A (zh) * | 2021-04-27 | 2023-11-28 | 原启生物科技(上海)有限责任公司 | 靶向bcma的嵌合抗原受体及其应用 |
| WO2023030272A1 (zh) * | 2021-08-30 | 2023-03-09 | 原启生物科技(上海)有限责任公司 | 抗gprc5d抗原结合蛋白及其用途 |
| JP2025505933A (ja) * | 2022-01-06 | 2025-03-05 | オリセル セラピューティクス カンパニー リミテッド | Ｍｓｌｎを標的とする抗原結合タンパク質及びその使用 |
| CN116656614A (zh) * | 2022-02-17 | 2023-08-29 | 杭州乾合细胞生物科技有限公司 | 一种靶向Her-2的CAR-NK细胞及其应用 |
| CN114891115B (zh) * | 2022-02-18 | 2025-07-18 | 杭州美中疾病基因研究院有限公司 | 一种car细胞疗法用核酸构建体及其慢病毒载体、细胞制剂和应用 |
| WO2024251290A1 (en) * | 2023-06-09 | 2024-12-12 | Suzhou Cure Genetics Biosciences Co., Limited | Engineered immune cells and uses thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3169703T4 (fi) * | 2014-07-16 | 2024-03-01 | Hinrich Abken | Kimeerinen antigeenireseptori ja sen käyttö |
| WO2017040287A1 (en) * | 2015-08-28 | 2017-03-09 | Serpin Pharma, Llc | Methods for treatment of diseases |
| GB201516972D0 (en) * | 2015-09-25 | 2015-11-11 | Epiontis Gmbh | LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells |
| KR20180063320A (ko) * | 2015-10-20 | 2018-06-11 | 카이트 파마 인코포레이티드 | T 세포 요법을 위한 t 세포를 제조하는 방법 |
| WO2018009972A1 (en) * | 2016-07-14 | 2018-01-18 | Peter Maccallum Cancer Institute | Chimeric antigen receptor modified t cells |
| EP3600418A4 (en) * | 2017-03-24 | 2021-01-13 | Yale University | LOW DENSITY LIPOPROTEIN RECEPTOR-BOUND PROTEIN-5 INHIBITION WHICH SUPPRESSES TUMOR FORMATION |
| CN108392492B (zh) * | 2017-12-28 | 2021-01-01 | 中国人民解放军第二军医大学东方肝胆外科医院 | Ldlr过表达在nk细胞过继治疗中的应用 |
-
2019
- 2019-03-25 WO PCT/CN2019/079576 patent/WO2019184886A1/zh not_active Ceased
- 2019-03-25 JP JP2020550874A patent/JP2021518149A/ja active Pending
- 2019-03-25 EP EP19776983.9A patent/EP3778876A4/en active Pending
- 2019-03-25 US US17/040,865 patent/US12005080B2/en active Active
- 2019-03-25 CN CN201980022452.0A patent/CN111918964B/zh active Active
-
2024
- 2024-11-01 JP JP2024193020A patent/JP2025023986A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021518149A5 (https=) | ||
| CN113784732B (zh) | 靶向bcma的工程化免疫细胞及其用途 | |
| CN113784733B (zh) | 靶向bcma的工程化免疫细胞及其用途 | |
| CN112426526B (zh) | 一种nk细胞的制备方法及其在治疗癌症中的应用 | |
| KR102110187B1 (ko) | 키메라 항원 수용체 단백질을 코딩하는 핵산 및 키메라 항원 수용체 단백질을 발현하는 t 림프구 | |
| KR20230098158A (ko) | Cd7 표적의 인간화 항체 및 이의 용도 | |
| JP2024069500A (ja) | 抗ｇｐｃ３一本鎖抗体を含むｃａｒ | |
| RU2018105963A (ru) | Антитело против глипикана-3 и его применение | |
| AU2019243448A1 (en) | Guidance and navigation control proteins and method of making and using thereof | |
| CN115135674A (zh) | 树突细胞激活性嵌合抗原受体和其用途 | |
| AU2025279705A1 (en) | Combination therapy using a chimeric antigen receptor | |
| JP2022542559A5 (https=) | ||
| WO2022222910A1 (zh) | 靶向gprc5d的抗体及其用途 | |
| EP4194472A1 (en) | Chimeric antigen receptor comprising novel co-stimulatory domain and use thereof | |
| CN108017717A (zh) | 一种用于体外高效定向扩增的嵌合抗原受体及其应用 | |
| US12415843B2 (en) | Antibody-interferon fusion proteins for enhancing adoptive T cell therapies for the treatment of cancer | |
| JP2023518578A (ja) | Ｈｐｖ感染細胞を標的とするための組成物及び方法 | |
| WO2021027785A1 (zh) | 共表达趋化因子受体的免疫效应细胞 | |
| US20240216427A1 (en) | Chimeric antigen receptors targeting splice variants of the extracellular matrix proteins tenascin c (tnc) and procollagen 11a1 (col11a1) | |
| CN115785279A (zh) | 包含新型共刺激结构域的嵌合抗原受体及其用途 | |
| CN121152813A (zh) | 细胞免疫疗法的组合物和方法 | |
| CN108101994A (zh) | 抗cd19抗体及其应用 | |
| CN116554328B (zh) | 一种靶向trbv12的单链抗体、car、car-nk细胞及应用 | |
| HK40110123A (zh) | 靶向bcma的工程化免疫细胞及其用途 | |
| AU2024276506A1 (en) | Immune effector cell and use thereof |